{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:13:28Z","timestamp":1775034808018,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["LONG17A0"],"award-info":[{"award-number":["LONG17A0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Low muscle mass is common in patients approaching lung transplantation and may be linked to worse post-transplant outcomes. Existing studies assessing muscle mass and post-transplant outcomes include few patients with cystic fibrosis (CF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between May 1993 and December 2018, 152 adults with CF received lung transplants at our institution. Of these, 83 met inclusion criteria and had usable computed tomography (CT) scans. Using Cox proportional hazards regression, we evaluated the association between pre-transplant thoracic skeletal muscle index (SMI) and our primary outcome of death after lung transplantation. Secondary outcomes, including days to post-transplant extubation and post-transplant hospital and intensive care unit (ICU) length of stay, were assessed using linear regression. We also examined associations between thoracic SMI and pre-transplant pulmonary function and 6-min walk distance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median thoracic SMI was 26.95 cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup> (IQR 23.97, 31.32) for men and 22.83 cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup> (IQR 21.27, 26.92) for women. There was no association between pre-transplant thoracic SMI and death after transplant (HR 1.03; 95% CI 0.95, 1.11), days to post-transplant extubation, or post-transplant hospital or ICU length of stay. There was an association between pre-transplant thoracic SMI and pre-transplant FEV1% predicted (b\u2009=\u20090.39; 95% CI 0.14, 0.63), with higher SMI associated with higher FEV1% predicted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Skeletal muscle index was low for men and women. We did not identify a significant relationship between pre-transplant thoracic SMI and post-transplant outcomes. There was an association between thoracic SMI and pre-transplant pulmonary function, confirming the potential value of sarcopenia as a marker of disease severity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02398-4","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T08:06:16Z","timestamp":1680163576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ann L","family":"Jennerich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha G","family":"Kapnadak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph B","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen J","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"issue":"9678","key":"2398_CR1","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"BP O'Sullivan","year":"2009","unstructured":"O\u2019Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891\u2013904.","journal-title":"Lancet"},{"key":"2398_CR2","unstructured":"Cystic Fibrosis Foundation Patient Registry Annual Data Report, Bethesda, Maryland; 2020."},{"issue":"10","key":"2398_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","volume":"38","author":"DC Chambers","year":"2019","unstructured":"Chambers DC, Cherikh WS, Harhay MO, Hayes D Jr, Hsich E, Khush KK, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1042\u201355.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2398_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","volume":"18","author":"KJ Ramos","year":"2019","unstructured":"Ramos KJ, Smith PJ, McKone EF, Pilewski JM, Lucy A, Hempstead SE, et al. Lung transplant referral for individuals with cystic fibrosis: Cystic fibrosis foundation consensus guidelines. J Cystic Fibros\u202f: Official J European Cystic Fib Soc. 2019;18(3):321\u201333.","journal-title":"J Cystic Fibros : Official J European Cystic Fib Soc"},{"issue":"3","key":"2398_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","volume":"19","author":"SG Kapnadak","year":"2020","unstructured":"Kapnadak SG, Dimango E, Hadjiliadis D, Hempstead SE, Tallarico E, Pilewski JM, et al. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros\u202f: official journal of the European Cystic Fibrosis Society. 2020;19(3):344\u201354.","journal-title":"J Cyst Fibros : official journal of the European Cystic Fibrosis Society"},{"key":"2398_CR6","doi-asserted-by":"crossref","unstructured":"Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2021.","DOI":"10.1016\/j.healun.2021.07.005"},{"issue":"9","key":"2398_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1164\/rccm.200903-0425OC","volume":"180","author":"DJ Lederer","year":"2009","unstructured":"Lederer DJ, Wilt JS, D\u2019Ovidio F, Bacchetta MD, Shah L, Ravichandran S, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med. 2009;180(9):887\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2398_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.healun.2010.05.005","volume":"29","author":"JG Allen","year":"2010","unstructured":"Allen JG, Arnaoutakis GJ, Weiss ES, Merlo CA, Conte JV, Shah AS. The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant. 2010;29(9):1026\u201333.","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"2398_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1164\/rccm.201405-0973OC","volume":"190","author":"JP Singer","year":"2014","unstructured":"Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D\u2019Ovidio F, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190(9):1012\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2398_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcf.2013.08.009","volume":"13","author":"FM Hollander","year":"2014","unstructured":"Hollander FM, van Pierre DD, de Roos NM, van de Graaf EA, Iestra JA. Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation. J Cyst Fibros\u202f: Official J European Cyst Fibros Soc. 2014;13(2):212\u20138.","journal-title":"J Cyst Fibros : Official J European Cyst Fibros Soc"},{"issue":"3","key":"2398_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1817-1737.160835","volume":"10","author":"K Chaikriangkrai","year":"2015","unstructured":"Chaikriangkrai K, Jhun HY, Graviss EA, Jyothula S. Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation. Ann Thorac Med. 2015;10(3):169\u201375.","journal-title":"Ann Thorac Med"},{"issue":"2","key":"2398_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.121.2.401","volume":"121","author":"WF Kanasky Jr","year":"2002","unstructured":"Kanasky WF Jr, Anton SD, Rodrigue JR, Perri MG, Szwed T, Baz MA. Impact of body weight on long-term survival after lung transplantation. Chest. 2002;121(2):401\u20136.","journal-title":"Chest"},{"issue":"2","key":"2398_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.healun.2003.09.040","volume":"24","author":"DA Culver","year":"2005","unstructured":"Culver DA, Mazzone PJ, Khandwala F, Blazey HC, Decamp MM, Chapman JT. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant. 2005;24(2):137\u201344.","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"2398_CR14","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1016\/j.transproceed.2010.07.078","volume":"42","author":"MM de la Torre","year":"2010","unstructured":"de la Torre MM, Delgado M, Paradela M, Gonzalez D, Fernandez R, Garcia JA, et al. Influence of body mass index in the postoperative evolution after lung transplantation. Transpl Proc. 2010;42(8):3026\u20138.","journal-title":"Transpl Proc"},{"issue":"5","key":"2398_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.transproceed.2014.04.004","volume":"46","author":"D Ruttens","year":"2014","unstructured":"Ruttens D, Verleden SE, Vandermeulen E, Vos R, van Raemdonck DE, Vanaudenaerde BM, et al. Body mass index in lung transplant candidates: a contra-indication to transplant or not? Transpl Proc. 2014;46(5):1506\u201310.","journal-title":"Transpl Proc"},{"issue":"5","key":"2398_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MCC.0b013e328364d570","volume":"19","author":"SM Bagshaw","year":"2013","unstructured":"Bagshaw SM, McDermid RC. The role of frailty in outcomes from critical illness. Curr Opin Crit Care. 2013;19(5):496\u2013503.","journal-title":"Curr Opin Crit Care"},{"issue":"12","key":"2398_CR17","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.healun.2014.06.003","volume":"33","author":"D Rozenberg","year":"2014","unstructured":"Rozenberg D, Wickerson L, Singer LG, Mathur S. Sarcopenia in lung transplantation: a systematic review. J Heart Lung Transplant. 2014;33(12):1203\u201312.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ctr.12683","volume":"30","author":"DJ Kelm","year":"2016","unstructured":"Kelm DJ, Bonnes SL, Jensen MD, Eiken PW, Hathcock MA, Kremers WK, et al. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transplant. 2016;30(3):247\u201355.","journal-title":"Clin Transplant"},{"issue":"7","key":"2398_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/tri.12961","volume":"30","author":"D Rozenberg","year":"2017","unstructured":"Rozenberg D, Mathur S, Herridge M, Goldstein R, Schmidt H, Chowdhury NA, et al. Thoracic muscle cross-sectional area is associated with hospital length of stay post lung transplantation: a retrospective cohort study. Transpl Int. 2017;30(7):713\u201324.","journal-title":"Transpl Int"},{"issue":"1","key":"2398_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1183\/09031936.00091607","volume":"33","author":"T Troosters","year":"2009","unstructured":"Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009;33(1):99\u2013106.","journal-title":"Eur Respir J"},{"issue":"1","key":"2398_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clnu.2013.04.012","volume":"33","author":"SJ King","year":"2014","unstructured":"King SJ, Nyulasi IB, Bailey M, Kotsimbos T, Wilson JW. Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha. Clin Nutr (Edinburgh, Scotland). 2014;33(1):150\u20135.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"5","key":"2398_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jcf.2017.02.007","volume":"16","author":"M Gruet","year":"2017","unstructured":"Gruet M, Troosters T, Verges S. Peripheral muscle abnormalities in cystic fibrosis: Etiology, clinical implications and response to therapeutic interventions. J Cyst Fibros\u202f: Official J European Cyst Fibros Soc. 2017;16(5):538\u201352.","journal-title":"J Cyst Fibros : Official J European Cyst Fibros Soc"},{"issue":"2","key":"2398_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","volume":"21","author":"MC Petersen","year":"2022","unstructured":"Petersen MC, Begnel L, Wallendorf M, Litvin M. Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis. J Cyst Fibros\u202f: official journal of the European Cystic Fibrosis Society. 2022;21(2):265\u201371.","journal-title":"J Cyst Fibros : official journal of the European Cystic Fibrosis Society"},{"issue":"2","key":"2398_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","volume":"211","author":"MJ Englesbe","year":"2010","unstructured":"Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211(2):271\u20138.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2398_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5152\/tjg.2016.16201","volume":"27","author":"T Izumi","year":"2016","unstructured":"Izumi T, Watanabe J, Tohyama T, Takada Y. Impact of psoas muscle index on short-term outcome after living donor liver transplantation. Turk J Gastroenterol\u202f: the official journal of Turkish Society of Gastroenterology. 2016;27(4):382\u20138.","journal-title":"Turk J Gastroenterol : the official journal of Turkish Society of Gastroenterology"},{"key":"2398_CR26","doi-asserted-by":"crossref","unstructured":"Kaido T, Tamai Y, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, et al. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Nutrition (Burbank, Los Angeles County, Calif). 2016.","DOI":"10.1016\/j.nut.2016.07.002"},{"issue":"1","key":"2398_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jcsm.12095","volume":"8","author":"M Kalafateli","year":"2016","unstructured":"Kalafateli M, Mantzoukis K, Choi Yau Y, Mohammad AO, Arora S, Rodrigues S, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score. J Cachexia Sarcopenia Muscle. 2016;8(1):113\u201321.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"2398_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/ajt.13732","volume":"16","author":"JL van Vugt","year":"2016","unstructured":"van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, JN IJ. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am Soc Transplant Am Soc Transpl Surg. 2016;16(8):2277\u201392.","journal-title":"Am Soc Transplant Am Soc Transpl Surg"},{"issue":"8","key":"2398_CR29","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.21037\/jtd.2016.07.06","volume":"8","author":"S Lee","year":"2016","unstructured":"Lee S, Paik HC, Haam SJ, Lee CY, Nam KS, Jung HS, et al. Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients. J Thorac Dis. 2016;8(8):2011\u20137.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2398_CR30","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1038\/s41598-018-29825-5","volume":"8","author":"BA Derstine","year":"2018","unstructured":"Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1):11369.","journal-title":"Sci Rep"},{"issue":"12","key":"2398_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1164\/rccm.201303-0429OC","volume":"187","author":"G Thabut","year":"2013","unstructured":"Thabut G, Christie JD, Mal H, Fournier M, Brugi\u00e8re O, Leseche G, et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med. 2013;187(12):1335\u201340.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2398_CR32","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1513\/pats.2009008-088TL","volume":"6","author":"FR Adler","year":"2009","unstructured":"Adler FR, Aurora P, Barker DH, Barr ML, Blackwell LS, Bosma OH, et al. Lung transplantation for cystic fibrosis. Proc Am Thorac Soc. 2009;6(8):619\u201333.","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"2398_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/tri.12721","volume":"29","author":"S Upala","year":"2016","unstructured":"Upala S, Panichsillapakit T, Wijarnpreecha K, Jaruvongvanich V, Sanguankeo A. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis. Transpl Int\u202f: official journal of the European Society for Organ Transplantation. 2016;29(3):285\u201396.","journal-title":"Transpl Int : official journal of the European Society for Organ Transplantation"},{"issue":"4","key":"2398_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.chest.2019.11.043","volume":"157","author":"KJ Ramos","year":"2020","unstructured":"Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, et al. Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united network for organ sharing registry study. Chest. 2020;157(4):898\u2013906.","journal-title":"Chest"},{"issue":"7","key":"2398_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2398_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/01.med.0000433071.11466.7f","volume":"20","author":"MF Bouchonville","year":"2013","unstructured":"Bouchonville MF, Villareal DT. Sarcopenic obesity: how do we treat it? Curr Opin Endocrinol Diabetes Obes. 2013;20(5):412\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"2398_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jocd.2015.04.013","volume":"18","author":"JA Cauley","year":"2015","unstructured":"Cauley JA. An Overview of Sarcopenic Obesity. J Clin Densitom\u202f: the official journal of the International Society for Clinical Densitometry. 2015;18(4):499\u2013505.","journal-title":"J Clin Densitom : the official journal of the International Society for Clinical Densitometry"},{"issue":"10","key":"2398_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11912-016-0546-5","volume":"18","author":"IP Carneiro","year":"2016","unstructured":"Carneiro IP, Mazurak VC, Prado CM. Clinical Implications of sarcopenic obesity in cancer. Curr Oncol Rep. 2016;18(10):62.","journal-title":"Curr Oncol Rep"},{"key":"2398_CR39","first-page":"78","volume":"203","author":"R Bernabei","year":"2014","unstructured":"Bernabei R, Martone AM, Vetrano DL, Calvani R, Landi F, Marzetti E. Frailty, physical frailty, sarcopenia: a new conceptual model. Stud Health Technol Inform. 2014;203:78\u201384.","journal-title":"Stud Health Technol Inform"},{"key":"2398_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2016.06.001","volume":"50","author":"J Angulo","year":"2016","unstructured":"Angulo J, El Assar M, Rodriguez-Manas L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med. 2016;50:1\u201332.","journal-title":"Mol Aspects Med"},{"key":"2398_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2016.07.021","volume":"35","author":"M Cesari","year":"2016","unstructured":"Cesari M, Nobili A, Vitale G. Frailty and sarcopenia: From theory to clinical implementation and public health relevance. Eur J Int Med. 2016;35:1\u20139.","journal-title":"Eur J Int Med"},{"issue":"2","key":"2398_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/archsurg.2011.1229","volume":"147","author":"JM Garonzik-Wang","year":"2012","unstructured":"Garonzik-Wang JM, Govindan P, Grinnan JW, Liu M, Ali HM, Chakraborty A, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg (Chicago, Ill\u202f: 1960). 2012;147(2):190\u20133.","journal-title":"Arch Surg (Chicago, Ill : 1960)"},{"issue":"1","key":"2398_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/ajt.12992","volume":"15","author":"MA McAdams-DeMarco","year":"2015","unstructured":"McAdams-DeMarco MA, Law A, King E, Orandi B, Salter M, Gupta N, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(1):149\u201354.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"2398_CR44","doi-asserted-by":"crossref","unstructured":"McAdams-DeMarco MA, King EA, Luo X, Haugen C, DiBrito S, Shaffer A, et al. Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Annals of surgery. 2016.","DOI":"10.1097\/SLA.0000000000002025"},{"issue":"8","key":"2398_CR45","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/ajt.12762","volume":"14","author":"JC Lai","year":"2014","unstructured":"Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(8):1870\u20139.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"11","key":"2398_CR46","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1164\/rccm.201506-1150OC","volume":"192","author":"JP Singer","year":"2015","unstructured":"Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192(11):1325\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2398_CR47","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2215\/CJN.09131010","volume":"6","author":"E Streja","year":"2011","unstructured":"Streja E, Molnar MZ, Kovesdy CP, Bunnapradist S, Jing J, Nissenson AR, et al. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol\u202f: CJASN. 2011;6(6):1463\u201373.","journal-title":"Clin J Am Soc Nephrol : CJASN"},{"issue":"3","key":"2398_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/CPT.0000000000000054","volume":"28","author":"S Mathur","year":"2017","unstructured":"Mathur S, Rodrigues N, Mendes P, Rozenberg D, Singer LG. Computed tomography-derived thoracic muscle size as an indicator of sarcopenia in people with advanced lung disease. Cardiopulm Phys Ther J. 2017;28(3):99\u2013105.","journal-title":"Cardiopulm Phys Ther J"},{"issue":"4","key":"2398_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1067\/j.cpradiol.2016.12.009","volume":"46","author":"T McClellan","year":"2017","unstructured":"McClellan T, Allen BC, Kappus M, Bhatti L, Dafalla RA, Snyder LD, et al. Repeatability of computerized tomography-based anthropomorphic measurements of frailty in patients with pulmonary fibrosis undergoing lung transplantation. Curr Probl Diagn Radiol. 2017;46(4):300\u20134.","journal-title":"Curr Probl Diagn Radiol"},{"issue":"5","key":"2398_CR50","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.athoracsur.2018.01.013","volume":"105","author":"FJ Fintelmann","year":"2018","unstructured":"Fintelmann FJ, Troschel FM, Mario J, Chretien YR, Knoll SJ, Muniappan A, et al. Thoracic skeletal muscle is associated with adverse outcomes after lobectomy for lung cancer. Ann Thorac Surg. 2018;105(5):1507\u201315.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2398_CR51","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Applied Physiol. 2004;97(6):2333\u20138.","journal-title":"J Applied Physiol"},{"issue":"9","key":"2398_CR52","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.acra.2017.02.008","volume":"24","author":"U Nemec","year":"2017","unstructured":"Nemec U, Heidinger B, Sokas C, Chu L, Eisenberg RL. Diagnosing sarcopenia on thoracic computed tomography: quantitative assessment of skeletal muscle mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol. 2017;24(9):1154\u201361.","journal-title":"Acad Radiol"},{"issue":"9","key":"2398_CR53","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1513\/AnnalsATS.202007-796OC","volume":"18","author":"JA Maheshwari","year":"2021","unstructured":"Maheshwari JA, Kolaitis NA, Anderson MR, Benvenuto L, Gao Y, Katz PP, et al. Construct and predictive validity of sarcopenia in lung transplant candidates. Ann Am Thorac Soc. 2021;18(9):1464\u201374.","journal-title":"Ann Am Thorac Soc"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02398-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T09:05:31Z","timestamp":1680167131000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02398-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the institutional review board at the University of Washington (STUDY00012301) and was performed in accordance with relevant guidelines and regulations. The need for written informed consent was waived by the institutional review board at the University of Washington due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Jennerich reports grants from NIH NHLBI, grants from Cystic Fibrosis Foundation Therapeutics, Inc., during the conduct of the study. Dr. Goss reports grants from Cystic Fibrosis Foundation, grants from European Commission, grants from NIH (NHLBI), grants from NIH (NIDDK and NCRR), during the conduct of the study; personal fees from Gilead Sciences, personal fees from Novartis, grants from NIH, grants from FDA, other from Boehringer Ingelheim, other from Vertex Pharmaceuticals, outside the submitted work. Dr. Ramos reports grants from CHEST Foundation in partnership with Vertex Pharmaceuticals, during the conduct of the study; grants from Cystic Fibrosis Foundation, grants from National Institutes of Health, outside the submitted work. Ms. Downey, and Drs. Kapnadak and Pryor have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}